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SUMMARY
The authors report a clinical case of toxicosis induced by ivermectin in a Collie dog with nervous and cardiac symptoms and 
emphasize the measures to be taken to control the disease, and bradycardia in particular.
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INTRODUCTION
The avermectin family, first described in 1978. is formed 
by macrocyclic lactones produced by Streptomyces aver- 
mitilis Ivermectin (M erck. M K-933) is a mixture of 
80% or more 22.23-dihydroavermectin B and 22.23-dihv- 
droavermcctin B in quantities not exceeding 2()9r of the 
total. Ivermectin differs from avermectin B (abamectin) 
because it is equally effective when administered orally or 
parenterally for the treatment of nematodes, insects, aca- 
rids and ticks parasiting domestic animals The drug 
acts by paralyzing the parasites through the inhibition of 
the transmission of stimuli from interneurons of the central 
cord, which are directed towards motor neurons This 
inhibition is made possible by a greater release of the neu­
rotransm itter gam m a-am inobutyric acid (GABA) at the 
presynaptic level and by potentiation of specific GABA 
receptors. Thus, the drug acts as a GABA agonist. In para­
sites. the BLOCKAGK is irreversible unless the neurons 
are washed with the antagonist picrotoxin . In contrast to 
invertebrates, in mammals that only have neurons that uti­
lize GABA as a neurotransm itter within the central ner­
vous system (CNS), ivermectin does not cross the menin­
geal barriers or act on cholinergic receptors. Medication 
with ivermectin has been followed by adverse reactions in 
horses, cats and dogs, especially Collies1’
The objetive of the present report was to inform veterinarians 
about the adverse cffcsts - bradycardia in particular - observed 
in a Collie dog injected subculaneously with ivermectin, that 
developed toxicosis with bradycardia and CNS depression.
CASE REPORT
We describe the therapeutic management of a male - Collie 
dog, aged seven years, seen at the Veterinary Hospital of
FCAV-UNESP . Campus de Jaboticabal. The animal pre­
sented intense bradycardia (HR = 55 hpm). severe CNS 
depression, tetraparesis with hyporeflexia except for the 
patellar reflex, sialorrhoea. decreased sensitivity to painful 
stimuli, dehydration, and diffuse alopecia of limbs, thorax 
and abdomen after receiving an unknown dose of ivermec­
tin* by subcutaneous route. Complementary tests included 
electrocardiography, which revealed intense sinus bradycar­
dia, and measurement of blood counts, alanine transferase 
(ALT): urea and creatinine gave normal results, except for 
an increase in total plasma protein. Treatm ent included 
constant electrocardiographic (LCG ) monitoring with an 
ECG Biomonitor (RF1) and continuous intravenous infusion 
of dopamine** at the rate of 10 g/ kg/ minute, increasing the 
heart rate to the normal level, since this is a sympathomime­
tic drug effective for the treatment of bradycardia.
We also administered fluids, vitamins of the B*** complex, 
antibiotics**** and gangliosides *****. according to a nor­
mal supporting therapy, and performed a pharyngotomy to 
force feeding, and emptying of the urinary bladder three 
times a day, with the use of an appropiate bed. Recovery 
occurred gradually over a period of 2 1 days.
* IVOMEC - Merck Sharp-Dohme
** RLVIVAN - Dopamine Zambon - Lab. Zambon
*** VALLEE BIOX AN COMPOUND - Vallee Nordeste S.A.
DISCUSSION AND CONCLUSIONS
The description of the present case is consistent with data 
from the veterinary scientific literature, reporting Collie 
dogs as highly susceptible to invermectin intoxication
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This susceptibility characterized by idiosyncrasy, was found 
to be extremely variable in a study by PAUL et al.* (1987). 
Another debatable aspect is that not only Collies may be 
affected by ivermectin toxicosis, but also Dobermans and 
Old England Sheepdogs have presented signs of neurologi­
cal alteration due to ivermectin lJ\
Studies on Collie dogs, sensitive or not to ivermectin, have 
demonstrated that there are no differences in plasma iver­
mectin concentrations'1' 16, or in brain electric activity detec­
ted by electroencephalography in intoxicated dogs'.
On this basis, two im portant questions arise: why are 
Collie dogs more sensitive than other dog breeds to iver­
mectin, and why are dogs more sensitive to iverm ectin 
than other species? These questions still await an answer. 
However, another, more immediate concern is how to treat 
dogs with ivermectin toxicosis. This problem is intimately- 
related to practical aspects o f veterinary medicine. The 
answer may be intensive patient care3-4-914, as well as admi­
nistration of picrotoxin as an antidote - a still debatable 
conduct'* - o r o f  p h y so s tig m in e , w ith  en co u rag in g  
results’14.
Nevertheless, the warning against the use of ivermectin in 
Collie dogs by injectable route and its indiscriminate use 
resulting in damage to the animal heath and a technical res­
ponsibility problem, the description of the present case is 
meant to alert veterinarians to the side effests on the cardio­
vascular system, leading to intense bradycardia and death. 
Thus, it is plausible to assume that this idiosyncratic reac­
tion may be managed successfully even in severely affected 
dogs, with a good interpretation of clinical signs and inten­
sive treatment of general condition, mainly in order to res­
tore cardiovascular function.
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RESUMO
Os autores relatam utn caso clínico de toxicose com ivermectin em um cão da raça Collie com sintomatologia nervosa e car- 
diomuscular. Assestam para todos os cuidados a serem tomados quanto ao controle da afecção. mormente a bradicardia.
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